This algorithm outlines the steps to guide the provider to assess and manage a child with tachycardia with a pulse.
The provider must succeed in the following goals to successfully manage children with tachycardia:
This algorithm outlines the steps for assessing and managing children presenting with tachycardia.
Pediatric Tachycardia With a Pulse Algorithm
The provider performs a quick assessment and does the following:
Using a 12-lead ECG or monitor, the team evaluates the rhythm and classifies it as:
A clinician administers an ECG to a child.
Typically, this will be obvious by a history consistent with a known cause. In infants, the rate is usually < 220 bpm. In children, the rate is usually < 180 bpm. P waves are present, normal, and upright. The R-R may be variable, but the PR interval will be constant.
An ECG reading displays sinus tachycardia.
Common causes of sinus tachycardia are activity, pain, fever, or other illnesses.
The provider assesses for cardiopulmonary compromise in the child. Signs are similar to those in an adult and include altered mentation, hypotension, and signs of shock. If the child has evidence of cardiopulmonary compromise, the team proceeds to Box 6; if not, the team proceeds to Box 11.
If the QRS is narrow (≤ 0.09 seconds), the team proceeds to Box 7.
If the QRS is wide (> 0.09 seconds), the team proceeds to Box 9.
The provider assesses the child and asks the parents about the onset of symptoms. The history of SVT usually indicates vague and nonspecific symptoms with sudden rate changes. In infants, the rate is often ≥ 220 bpm, and the rate in children is usually > 180 bpm. P waves are often abnormal or absent, and the heart rate is not variable.
If intravascular access is available, the team administers adenosine. The first dose is 0.1 mg/kg by rapid bolus (dose not to exceed 6 mg). This can be followed by a second dose of 0.2 mg/kg by rapid bolus (dose not to exceed 12 mg).
If IV/IO access is NOT available or adenosine is not effective, the team performs synchronized cardioversion.
A wide QRS may indicate ventricular tachycardia with a pulse.
If the child’s condition allows, the team can consider sedation, but definitive treatment should not be delayed.
The team immediately performs synchronized cardioversion with an initial energy dose of 0.5–1.0 J/kg. If this dose is not effective, the team increases the dose to 2 J/kg. The team calls for expert consultation.
If the QRS is narrow (≤ 0.09 seconds), the team proceeds to Box 12.
If the QRS is wide (> 0.09 seconds), the team proceeds to Box 15.
The provider assesses the child and asks the parents about the onset of symptoms. The history of SVT usually indicates vague and nonspecific symptoms with a history of sudden rate changes. In infants, the rate is often ≥ 220 bpm, and the rate in children is usually > 180 bpm. P waves are often abnormal or absent, and the heart rate is not variable.
Since the child is not compromised, the team leader considers using vagal maneuvers to terminate the SVT.
If IV or IO access is available, the team administers adenosine. The first dose is 0.1 mg/kg by rapid bolus (dose not to exceed 6 mg). This can be followed by a second dose of 0.2 mg/kg by rapid bolus (dose not to exceed 12 mg).
A wide QRS may indicate ventricular tachycardia with a pulse.
If the rhythm is regular with monomorphic QRS complexes, the provider considers the administration of adenosine. The first dose is 0.1 mg/kg by rapid bolus (dose not to exceed 6 mg). This can be followed by a second dose of 0.2 mg/kg by rapid bolus (dose not to exceed 12 mg).
The team now considers expert consultation.